Yun Xu, Ye Xu, Ming Tang, Cong Li, Yuchen Wu, Yuedi Dai, Xiaopin Ji, Zhe Cui, Xiaodong Zhu. "Fruquintinib plus FOLFIRI or mFOLFOX6 as second-line therapy for patients with
                    <i>RAS</i>
                    -mutant metastatic colorectal cancer (mCRC): A phase II, multicenter, open-label study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3528